Helping adults at drinking venues in Kenya and Uganda start and stay on HIV prevention
Innovative strategies to promote biomedical HIV prevention uptake and retention among high-risk adults at drinking venues in Kenya and Uganda
This project tries to help adults who drink at bars in Kenya and Uganda get and keep using HIV prevention tools like PrEP and PEP.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11120965 on NIH RePORTER |
What this research studies
You would be approached at alcohol-serving venues and offered HIV testing alongside other health screenings so getting tested feels more routine and less stigmatizing. The team plans to recruit over 2,000 adults from bars and similar places in Kenya and Uganda and link people who test negative but are at risk to PrEP or PEP. Outreach uses a multi-disease mobilization strategy designed to reach people who drink heavily and their partners, and staff will follow up to support continued use of prevention. The goal is to see whether this venue-based, multi-disease approach improves initial uptake and longer-term retention in biomedical HIV prevention.
Who could benefit from this research
Good fit: Adults age 21 and older who frequent alcohol-serving venues in Kenya or Uganda and are at increased risk of HIV are ideal candidates for this work.
Not a fit: People who do not attend these venues, are not at elevated sexual risk, or are already fully engaged in prevention care may not see direct benefit from this project.
Why it matters
Potential benefit: If successful, this approach could help more people who frequent drinking venues start and stay on PrEP/PEP, lowering their risk of HIV infection.
How similar studies have performed: Related outreach and multi-disease screening efforts have increased HIV testing uptake in community settings, but using them specifically to improve long-term PrEP/PEP retention is less tested and partly novel.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Chamie, Gabriel — University of California, San Francisco
- Study coordinator: Chamie, Gabriel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.